Temporal and spatial distribution of interleukin-1 beta in balloon injured porcine coronary arteries

Cardiovasc Res. 1999 Oct;44(1):156-65. doi: 10.1016/s0008-6363(99)00175-3.

Abstract

Objective: Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine with a wide range of biological activities. We determined the distribution of IL-1 beta following percutaneous transluminal coronary angioplasty (PTCA) of porcine arteries, and the presence of caspase-1 (required for the activation of IL-1 beta).

Methods: Oversized balloon angioplasty was performed in Yorkshire White pigs and the vessels excised at selected intervals (1, 6, 18 h, 3, 7, and 14 days) post-PTCA. IL-1 beta and caspase-1 were then identified using reverse transcription polymerase chain reaction (RT-PCR), in situ RT-PCR, and immunohistochemistry.

Results: IL-1 beta protein was detected in the inflammatory infiltrate up to 3 days after PTCA. Luminal endothelial cells contained IL-1 beta at 1 h, with peak expression at 3-7 days. Adventitial capillaries were IL-1 beta-positive at all timepoints. IL-1 beta was detected in adventitial cells at 3 days, with reduced levels at 7 and 14 days. At 7 days, neointimal cells were also IL-1 beta positive. No IL-1 beta was detected in non-PTCA control arteries. RT-PCR demonstrated IL-1 beta mRNA expression to be induced at 1 h, and absent at 3 days. In situ RT-PCR revealed this expression to be distributed throughout the arterial layers at 6 h, but localized to the adventitia at 18 h, with a baseline expression in the adventitial layer of non-PTCA controls. Caspase-1 was detected in luminal endothelial cells from 6 h, in adventitial cells from 3 days, and in neointimal cells from 7 days post-PTCA. This expression colocalized with IL-1 beta, indicating the potential for the IL-1 beta present to become activated.

Conclusions: We conclude that IL-1 beta is synthesised, in conjunction with caspase-1, by endothelial, inflammatory, and adventitial cells early (within 3 days) after PTCA, with decreased levels at later timepoints, suggesting that it has a key role to play in the early stages of healing following PTCA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Animals
  • Caspase 1 / metabolism
  • Coronary Disease / immunology
  • Coronary Disease / therapy*
  • Coronary Vessels / immunology
  • Coronary Vessels / injuries*
  • Immunohistochemistry
  • Interleukin-1 / analysis
  • Interleukin-1 / genetics
  • Interleukin-1 / metabolism*
  • Models, Biological
  • RNA, Messenger / analysis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Swine
  • Time Factors
  • Wound Healing

Substances

  • Interleukin-1
  • RNA, Messenger
  • Caspase 1